載入...
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
PURPOSE: Oral mucositis is a significant toxicity of cytotoxic chemo- and radiation-therapy used to treat cancer. Palifermin is the first pharmaceutical/biological agent approved for the intervention of oral mucositis. The major objective of this review is to evaluate the evidence supporting the use...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899789/ https://ncbi.nlm.nih.gov/pubmed/20694076 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|